Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

I-tech

53.80 SEK

-0.19 %

Less than 1K followers

ITECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for I-tech

2019202020212022202320242025
Revenue45.652.852.983.6120.9179.5168.1
growth-%15.9 %0.2 %58.1 %44.5 %48.5 %-6.3 %
EBITDA1.23.63.220.131.453.748.5
EBIT-7.0-5.2-4.712.023.445.541.0
Profit before taxes-7.1-6.0-3.313.425.549.241.8
Net income8.4-4.8-2.610.620.239.033.2
EPS0.71-0.40-0.220.901.703.302.80
Dividend0.000.000.000.001.501.001.25
Dividend ratio0.0 %-0.0 %-0.0 %0.0 %88.2 %30.3 %44.6 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%2.7 %6.8 %6.1 %24.0 %26.0 %29.9 %28.8 %
EBIT-%-15.4 %-9.8 %-8.9 %14.4 %19.4 %25.3 %24.4 %
ROE7.6 %-4.5 %-2.5 %9.2 %14.8 %24.8 %19.0 %
ROI6.4 %-4.0 %-2.3 %8.5 %13.3 %22.5 %17.1 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.